Y 134 |
Y 134 |
849662-80-2 |
(S)-2-Amino-4-(4-(bis(4-fluorophenyl)methyl)piperazin-1-yl)-1-(isoindolin-2-yl)butane-1,4-dione |
(S)-2-Amino-4-(4-(bis(4-fluorophenyl)methyl)piperazin-1-yl)-1-(isoindolin-2-yl)butane-1,4-dione |
847928-32-9 |
PyriMido[5',4':5,6]pyriMido[1,2-a]benziMidazol-5(6H)-one, 6-(2,6-diMethylphenyl)-2-[[4-(4-Methyl-1-piperazinyl)phenyl]aMino]- |
6-(2,6-二甲基苯基)-2-[[4-(4-甲基-1-哌嗪基)苯基]氨基]-嘧啶并[5',4':5,6]嘧啶并[1,2-A]苯并咪唑-5(6H)-酮 |
847950-09-8 |
HKI 357 |
HKI 357 |
848133-17-5 |
SHA 68 |
SHA 68 |
847553-89-3 |
ICG-001 |
ICG-001 |
847591-62-2 |
Mitoquinone mesylate |
米托蒽醌甲磺酸盐 |
845959-50-4 |
4-(4-FORMYL-PHENOXY)-PIPERIDINE-1-CARBOXYLIC ACID TERT-BUTYL ESTER |
4-(4-甲酰基苯氧基)哌啶-1-羧酸叔丁酯 |
207798-38-7 |
RILMENIDINE HEMIFUMARATE SALT |
RILMENIDINE HEMIFUMARATE SALT |
207572-68-7 |
(S)-2-(8-(2-(6-(methylamino)pyridin-2-yl)ethoxy)-3-oxo-2-(2,2,2-trifluoroethyl)-2,3,4,5-tetrahydro-1H-benzo[c]azepin-4-yl)acetic acid |
SB273005 INTEGRIN抑制剂 |
205678-31-5 |
1,2,9,10-TETRACHLORODECANE |
1,2,9,10-TETRACHLORODECANE |
205646-11-3 |
1-[(3S,1R)-3-N-BOC-aminocyclopentyl]-1-ethanone |
1 - ((3S,1R)-3-叔丁氧羰基氨基环戊基)-1-乙酮 |
204913-01-9 |
SID 487795 |
NSC617145 |
203115-63-3 |
laninamivir octanoate |
辛酸拉尼米韦 |
203120-46-1 |
1-(2,4-DICHLOROPHENYL)-5-(4-IODOPHENYL)-4-METHYL-N-4-MORPHOLINYL-1H-PYRAZOLE-3-CARBOXAMIDE |
1-(2,4-二氯苯基)-5-(4-碘苯基)-4-甲基-N-吗啉-1H-吡唑-3-甲酰胺 |
202463-68-1 |
(S)-3,4-DCPG |
(S)-3,4-二甲酸苯基甘氨酸 |
201730-11-2 |
H-BETA-ALA-AMC TFA |
H-BETA-ALA-AMC TFA |
201847-54-3 |
3-OXO-3,4-DIHYDRO-2H-BENZO[1,4]OXAZINE-6-CARBALDEHYDE |
3-氧代-3,4-二羟基-2H-苯[1,4]恶嗪-6-甲醛 |
200195-15-9 |
3-(2-Thienyl)benzoic acid |
3-(2-Thienyl)benzoic acid |
29886-63-3 |
S-[2-(4-PYRIDYL)ETHYL]-L-CYSTEINE |
S-2-(4-吡啶基乙基)-L-半胱氨酸 |
28809-04-3 |